Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 07/26/24 11:41:00 on US and Canada Markets.
Astellas Receives Positive CHMP Opinion for Zolbetuximab in Combination with Chemotherapy for Treatment of Advanced Gastric and Gastroesophageal Junction Cancer PR Newswire - If approved by the European Commission, zolbetuximab would become the first and only CLDN18.2-targeted...
TORONTO, July 26, 2024 (GLOBE NEWSWIRE) -- Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is pleased to report the results of its Annual General and Special Meeting of shareholders held on July 26, 2024 (the "Meeting"). ...
Astellas Receives Positive CHMP Opinion for PADCEV™ (enfortumab vedotin) in combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer PR Newswire - If approved, enfortumab vedotin in combination with pembrolizumab ...
Kellanova Declares Regular Dividend of $0.57 per Share PR Newswire CHICAGO , July 26, 2024 /PRNewswire/ -- Kellanova (NYSE: K) today announced that its Board of Directors declared a dividend of $0.57 per share on the common stock of Kellanova, payable on...
WHEAT RIDGE, CO / ACCESSWIRE / July 26, 2024 / Lifeloc Technologies, Inc. (OTC PINK:LCTC) (the "Company"), a global leader in the development and manufacturing of breath alcohol testing devices, has announced the appointment of Adam Kashenberg, president and CEO of Colorado Biolabs, Inc., to its...
Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA Nephropathy PR Newswire STOCKHOLM , July 26, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Ca...
Canadian Investment Regulatory Organization Trade Resumption - NPRA Canada NewsWire VANCOUVER, BC , July 26, 2024 /CNW/ - Trading resumes in: Company: Nepra Foods Inc. CSE Symbol: NPRA All Issues: Yes Resumption (ET): 11:30 AM ...
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza Canada NewsWire TORONTO , July 26, 2024 /CNW/ - The National Advisory Committee on Immunization's (NACI) annual Statement...
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza Canada NewsWire TORONTO , July 26, 2024 /CNW/ - The National Advisory Committee on Immunization's (NACI) annual Statement...
2024-07-26 11:15:04 ET RBC Capital analyst issues OUTPERFORM recommendation for CCK on July 26, 2024 09:31AM ET. The previous analyst recommendation was Outperform. CCK was trading at $86.42 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.99%Change Percent:
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
allarity.com Website: